Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SNYR
SNYR logo

SNYR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Synergy CHC Corp (SNYR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.270
1 Day change
-3.24%
52 Week Range
4.000
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Synergy CHC Corp (SNYR) is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is sharply down in pre-market (-11.07%), technicals are still bearish overall, there is no supportive news catalyst, and both AI Stock Pick and SwingMax show no buy signal today. Based on the data provided, the clear decision is to avoid buying now.

Technical Analysis

Current pre-market price is 0.2491, which is below the pivot level of 0.294 and near S1 at 0.238, showing weakness. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, which confirms the longer-term downtrend. MACD histogram is positive and expanding, but RSI_6 at 50.428 is neutral and not strong enough to offset the bearish trend. Overall technical setup remains weak despite a small short-term MACD improvement.

Positive Catalysts

  • No news in the recent week. The only mild positive is that the MACD histogram is above zero and expanding, which suggests some short-term momentum improvement. Similar candlestick pattern analysis suggests a small chance of near-term upside, but the expected move is minimal.

Neutral/Negative Catalysts

  • Pre-market price is down 11.07%, which is a strong negative signal. Bearish moving averages indicate the stock is still in a downtrend. There was no recent news to support sentiment, hedge funds and insiders are both neutral, and AI Stock Pick as well as SwingMax both show no signal today. Congress trading data is also unavailable, so there is no influential buying support.

Financial Performance

Financial snapshot data was unavailable due to an error, so the latest quarter financials cannot be assessed. As a result, there is no evidence here of accelerating growth or improving fundamentals to support a long-term buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible Wall Street upgrade/downgrade trend to support the stock. The available Wall Street view appears neutral to weak because there are no bullish analyst catalysts, no positive news flow, and no insider or hedge fund accumulation.

Wall Street analysts forecast SNYR stock price to rise
2 Analyst Rating
Wall Street analysts forecast SNYR stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.278
sliders
Low
5
Averages
6
High
7
Current: 0.278
sliders
Low
5
Averages
6
High
7
Ascendiant
Edward Woo
Buy
initiated
$5
AI Analysis
2026-02-02
Reason
Ascendiant
Edward Woo
Price Target
$5
AI Analysis
2026-02-02
initiated
Buy
Reason
Ascendiant analyst Edward Woo initiated coverage of Synergy CHC with a Buy rating and $5 price target. Synergy provides consumer health care, beauty, and lifestyle products, the analyst tells investors in a research note. The firm sees large market opportunities for the company's brain health supplement FOCUSfactor.
Roth Capital
Sean McGowan
Buy
downgrade
$10 -> $7
2025-11-14
Reason
Roth Capital
Sean McGowan
Price Target
$10 -> $7
2025-11-14
downgrade
Buy
Reason
Roth Capital analyst Sean McGowan lowered the firm's price target on Synergy CHC to $7 from $10 and keeps a Buy rating on the shares. The company made good progress during Q3, broadening its distribution footprint for both supplements and beverages and continuing to expand geographically, though its results came up short of expectations due in part to cash being tight prior to the company's recent equity raise, the analyst tells investors in a research note. Roth adds however that Synergy now has the capital needed to post significant growth in 2026.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SNYR
Unlock Now

People Also Watch